On December 27, 2025, Indian Immunologicals Limited (IIL), one of India’s leading vaccine manufacturers, which produces Abhayrab, said a counterfeit batch of its human anti-rabies vaccine, Abhayrab, was no longer available on the shelves. According to Tushar Tayal, associate director, Internal Medicine, CK Birla Hospital, Gurugram, “Repeat rabies vaccination is allowed and safe. The rabies vaccine is an inactivated vaccine, and as such, it does not contain a live virus. The World Health Organization notes that India is endemic for rabies, and accounts for 36% of the world’s rabies deaths. Rabies deaths in humans are 100% preventable through prompt and appropriate medical care.

Source: The Hindu January 04, 2026 04:57 UTC